Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Payables: 2017-2018

Historic Payables for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to $1.4 million.

  • Astria Therapeutics' Payables rose 105.92% to $2.2 million in Q3 2019 from the same period last year, while for Sep 2019 it was $6.5 million, marking a year-over-year decrease of 24.69%. This contributed to the annual value of $1.4 million for FY2018, which is 56.70% down from last year.
  • According to the latest figures from FY2018, Astria Therapeutics' Payables is $1.4 million, which was down 56.70% from $3.3 million recorded in FY2017.
  • In the past 5 years, Astria Therapeutics' Payables registered a high of $3.3 million during FY2017, and its lowest value of $1.4 million during FY2018.
  • For the 2-year period, Astria Therapeutics' Payables averaged around $2.3 million, with its median value being $2.3 million (2017).
  • Data for Astria Therapeutics' Payables shows a maximum YoY slumped of 56.70% (in 2018) over the last 5 years.
  • Astria Therapeutics' Payables (Yearly) stood at $3.3 million in 2017, then tumbled by 56.70% to $1.4 million in 2018.